glp-1 expression in pancreatic α-cells. (A) Percentage of Enhancing GLP-1 expression via IVT
Description
In the trial, people on the Wegovy pill lost about 13.6% of their body weight, while people on a placebo lost about 2% after 71 weeks

Its fine to start GLP-1 again, but once breastfeeding stops and your doctor gives the go-ahead

For longer-acting preparations, there is no clinical need to link injections to meals, though some patients prefer to establish a routine that includes a regular mealtime as a reminder

Patients who continue the max dose of GLP-1 therapy for extended periods (beyond the initial 1620 weeks) can experience more gradual but sustained weight loss

Whilst beneficial for weight loss and glycaemic control, a substantial caloric deficitparticularly if nutritional intake becomes inadequatemay contribute to fatigue and reduced energy levels

Criminal counterfeiters and questionable suppliers are deliberately exploiting this trend by promoting these products sometimes very aggressively on social media, websites or via direct advertising in particular
